Keyphrases
Action Potential Duration
42%
Active Components
14%
Arrhythmia
14%
Atrial Fibrillation
100%
Atrial Myocytes
14%
Beta-blockers
14%
Co-expression
14%
Constitutively Active
14%
Deactivation
14%
Delayed Rectifier Potassium Current
14%
Electrophysiological Recordings
14%
Enhanced Sensitivity
14%
Familial Atrial Fibrillation
28%
Function Features
14%
Gain-of-function
100%
Gain-of-function mutation
14%
Genetic Parameters
14%
Heteromer
14%
Hyperpolarized
14%
I Ks
28%
KCNE1
42%
KCNQ1
100%
KCNQ1 mutation
100%
Large Amplitude
14%
Left Atrial
14%
Pharmacological Effects
14%
Pharmacological Properties
14%
Potassium Current
14%
Selective Targeting
100%
Specific Treatment
14%
Steady State
14%
Targeted Inhibition
14%
Therapeutic Targeting
14%
Use-dependent
14%
Ventricular Arrhythmia
14%
Voltage Dependence
14%
Biochemistry, Genetics and Molecular Biology
Action Potential Duration
60%
Atrial Fibrillation
100%
Cardiac Dysrhythmia
40%
Electric Potential
20%
Electrophysiological Procedures
20%
Familial Atrial Fibrillation
40%
Gain of Function Mutation
20%
Genotyping
20%
KCNE1
60%
Leporidae
20%
Potassium Current
20%
Steady State
20%
Wild Type
100%
Neuroscience
Action Potential
100%
Atrial Fibrillation
100%
Cardiac Dysrhythmia
66%
Familial Atrial Fibrillation
66%
Gain of Function Mutation
33%
Myocyte
33%
Potassium Current
33%
Medicine and Dentistry
Action Potential Duration
100%
Arrhythmia
33%
Atrial Fibrillation
100%
Cardiac Dysrhythmia
33%
Familial Atrial Fibrillation
66%
Gain of Function Mutation
33%
Potassium Current
33%
Steady State
33%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
100%
Heart Arrhythmia
40%
Isotopes of Potassium
20%
Leporidae
20%